Back to Screener

Healthcare

Sona Nanotech Inc.(SNANF)

Live Price

Offline

$0.222

+0.00% today

1Y Change

-33.00%

Window

Jun 23, 2025 โ†’ May 29, 2026

Market Cap
$40.00M
Revenue Growth
0.0%
EPS Growth
-7.4%
Dividend Yield
0.0%

Coverage: 236 bars ยท Jun 23, 2025 โ†’ May 29, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Sona Nanotech Inc. (SNANF) is a Healthcare stock with a market cap of $40.00M and listed on OTC. The stock last traded around $0.22 and down 33.0% across the available one-year price window (Jun 23, 2025 โ†’ May 29, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -7.4%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -7.4%, free cash flow -0.1% with operating margin 0.0% and ROIC -1878.2%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SNANF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SNANF

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SNANF Max Drawdown

-61.71%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SNANF and SPY.

Calendar-year return history is still loading or unavailable.

EPS Consensus

-0.08

Range -0.08 โ†’ -0.08

No analyst count

vs prior: -20.0%

Revenue Outlook

$0.0B

Range $0.0B โ†’ $0.0B

No analyst count

Consensus Spread

EPS spread0.0%
Revenue spreadโ€”

Lower spread suggests tighter agreement across covering analysts.

Trend

EPS trend

Consensus average across visible periods

-0.08
Latest visible period
Q1 2028Q2 2029
6 visible pointstrend: -20.0%

Trend

Revenue trend

Average analyst revenue estimate

$0.0B
Latest visible period
Q1 2028Q2 2029
6 visible points

Timeline

Analyst forecast ladder

Sorted by period end date. Includes both cached rows and live fallbacks from FMP.

Q2 2029
Ends Apr 30, 2029
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.08
-0.08 to -0.08
No analyst count
EPS: No analyst count
May 1, 07:01 PM UTC
stable/analyst-estimates
Q1 2029
Ends Jan 31, 2029
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.07
-0.07 to -0.07
No analyst count
EPS: No analyst count
May 1, 07:01 PM UTC
stable/analyst-estimates
Q4 2028
Ends Oct 31, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.07
-0.07 to -0.07
No analyst count
EPS: No analyst count
May 1, 07:01 PM UTC
stable/analyst-estimates
Q3 2028
Ends Jul 31, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.06
-0.06 to -0.06
No analyst count
EPS: No analyst count
May 1, 07:01 PM UTC
stable/analyst-estimates
Q2 2028
Ends Apr 30, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.06
-0.06 to -0.06
No analyst count
EPS: No analyst count
May 1, 07:01 PM UTC
stable/analyst-estimates
Q1 2028
Ends Jan 31, 2028
quarter
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.06
-0.06 to -0.06
No analyst count
EPS: No analyst count
May 1, 07:01 PM UTC
stable/analyst-estimates

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.